Metformin and Gadavist drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metformin (metformin hydrochloride) and Gadavist (gadobutrol). Common drug interactions include anaphylactic reaction among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Metformin and Gadavist. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.

What is Gadavist?

Gadavist has active ingredients of gadobutrol. eHealthMe is studying from 3,726 Gadavist users. Check the latest studies of Gadavist.



On Apr, 27, 2026

15 people who take Metformin and Gadavist together, and have interactions are studied.

Metformin and Gadavist drug interactions.

What are the common drug interactions of Metformin and Gadavist, by gender? *:

female:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Cough
  3. Dyspnoea (difficult or laboured respiration)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Wheezing (a high-pitched whistling sound made while you breath)
  7. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  8. Premature baby
  9. Pruritus (severe itching of the skin)
  10. Blood creatinine increased

male:

  1. Headache (pain in head)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Colonoscopy
  4. Cough
  5. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  6. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  7. Drug ineffective
  8. Dyspnoea (difficult or laboured respiration)
  9. Erythema (redness of the skin)
  10. Hyperhidrosis (abnormally increased sweating)

What are the common drug interactions of Metformin and Gadavist, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood creatinine increased
  2. Glomerular filtration rate decreased

30-39:

n/a

40-49:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Premature baby
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Blood pressure decreased
  5. Eye swelling
  6. Headache (pain in head)
  7. Nausea (feeling of having an urge to vomit)
  8. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Throat irritation

50-59:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Cough
  3. Dyspnoea (difficult or laboured respiration)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Wheezing (a high-pitched whistling sound made while you breath)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Chest pain
  8. Arthralgia (joint pain)
  9. Bone pain
  10. Burning sensation

60+:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Tinnitus (a ringing in the ears)
  4. Arthralgia (joint pain)
  5. Cold sweat
  6. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  7. Dyspnoea (difficult or laboured respiration)
  8. Erythema (redness of the skin)
  9. Headache (pain in head)
  10. Hyperhidrosis (abnormally increased sweating)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 2 people, 13.33%
  2. Malignant Melanoma (skin cancer rises from melancytes): 2 people, 13.33%
  3. High Blood Pressure: 2 people, 13.33%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 6.67%
  5. Chest Pain: 1 person, 6.67%
  6. Constipation: 1 person, 6.67%
  7. Depression: 1 person, 6.67%
  8. Diarrhea: 1 person, 6.67%
  9. Dizziness: 1 person, 6.67%
  10. Hormone Level Abnormal: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Metformin and Gadavist?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metformin and Gadavist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gadavist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gadavist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride and gadobutrol (the active ingredients of Metformin and Gadavist, respectively), and Metformin and Gadavist (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: